Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.
Related Posts
European stocks turn negative as earnings, Fed decision hold spotlight; Novartis falls 3%
European stocks fell into negative territory on Tuesday, amid a flurry of corporate earnings.
Markets across Asia rebound; Chinese markets set to extend gains
Mainland China’s CSI 300 has notched a five-day winning streak, hitting its highest levels in almost two months
China targets U.S. services and other areas after decrying ‘meaningless’ tariff hikes on goods
Beijing has wielded a wide range of punitive measures in recent days to strike back at Washington, including steps targeting…